Improved epicardial cardiac fibroblast generation from iPSCs

Area of Science:

• Stem cell biology
• Cardiovascular research
• Cellular reprogramming

Background:

• Human embryonic stem cells and somatic cell reprogramming have enabled generation of various cell types.
• Robust protocols exist for many cell types, but generating cardiac fibroblasts (CFs) remains a challenge.
• Recent methods focus on a developmentally conserved epicardial pathway for CF generation.

Purpose of the Study:

• To report a method for generating cardiac fibroblasts (CFs) with improved stability and function.
• To provide detailed guidance on media conditions, seeding densities, and extracellular matrix harvesting.
• To demonstrate the efficacy of the developed protocol by comparing resultant cells to primary CFs.

Main Methods:

• Prolonged exposure of cells to specific growth factors, including bFGF.
• Induction of fibroblast spindle-like morphology and chromatin architecture.
• Characterization of marker expression and extracellular matrix production.
• Optimization of media conditions, seeding densities, and harvest timepoints.

Main Results:

• Prolonged growth factor exposure induced fibroblast morphology and chromatin structure similar to primary CFs.
• Specific media conditions and protocols were established for cell growth and assays.
• Resultant cells demonstrated comparable marker expression and matrix competency to primary human CFs.
• An increasingly stable phenotype was observed in the generated CFs.

Conclusions:

• This study provides enhanced guidance for generating cardiac fibroblasts (CFs) through an epicardial pathway.
• The optimized protocol results in CFs with stable phenotypes and functional matrix production.
• These findings contribute to advancing regenerative medicine and disease modeling in cardiovascular research.